1960
DOI: 10.1016/s0140-6736(60)90470-0
|View full text |Cite
|
Sign up to set email alerts
|

Bretylium Tosylate in the Treatment of Hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

1960
1960
1962
1962

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 2 publications
0
3
0
Order By: Relevance
“…As regards the other forms of combined treatment, it seems that guanethidine can be suitably combined with hydralazine. Three cases (3,11,12) that were previously not able to tolerate hydralazine even in small doses on account of palpitations of the heart and headache, were able to stand hydralazine better when combined with guanethidine. This is possibly due to the fact that the bradycardia1 effect of guanethidine offsets the tachycardia obtained by hydralazine medication.…”
Section: Discussionmentioning
confidence: 96%
“…As regards the other forms of combined treatment, it seems that guanethidine can be suitably combined with hydralazine. Three cases (3,11,12) that were previously not able to tolerate hydralazine even in small doses on account of palpitations of the heart and headache, were able to stand hydralazine better when combined with guanethidine. This is possibly due to the fact that the bradycardia1 effect of guanethidine offsets the tachycardia obtained by hydralazine medication.…”
Section: Discussionmentioning
confidence: 96%
“…There has been no recurrence on guanethidine. Other workers have experienced a higher incidence of mental changes (Evanson and Sears, 1960).…”
Section: Hypertensionmentioning
confidence: 99%
“…Introduced by Boura et al (1959), bretylium tosylate blocks the sympathetic nervous system by its selective accumulation in sympathetic ganglia and post-ganglionic sympathetic fibres. Following on encouraging reports of clinical trials (Boura et al, 1959;Dollery et al, 1960a) there has been a considerable correspondence Lowther, 1960a, 1960b;Evanson and Sears, 1960;Lowe and Rosenheim, 1960;Somers, 1960a) recording unfavourable experiences with bretylium. Ultimately Dollery et al (1960b) abandoned the use of bretylium because of the high incidence of drug resistance.…”
mentioning
confidence: 99%